Exact Mass: 527.1692419999999
Exact Mass Matches: 527.1692419999999
Found 82 metabolites which its exact mass value is equals to given mass value 527.1692419999999
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Daunorubicin
C27H29NO10 (527.1791374000001)
Daunorubicin is only found in individuals that have used or taken this drug. It is a very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]Daunorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D106
5-Carboxytetramethylrhodamine succinimidyl ester
C29H25N3O7 (527.1692419999999)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
Esorubicin
C27H29NO10 (527.1791374000001)
D000970 - Antineoplastic Agents
N-Demethylmenogaril
C27H29NO10 (527.1791374000001)
Cerubidin
C27H29NO10 (527.1791374000001)
Pirozadil
C27H29NO10 (527.1791374000001)
(2,6-epoxy-1,2alpha,3beta,4alpha,5alpha-pentahydroxy)hexane-(1->6)-5,6-dihydrochelerythrine|maclekarpine D
C27H29NO10 (527.1791374000001)
Daunorubicin
C27H29NO10 (527.1791374000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent A natural product found in Actinomadura roseola. D004791 - Enzyme Inhibitors
Cys Asp Gln Tyr
C21H29N5O9S (527.1685904000001)
Cys Asp Tyr Gln
C21H29N5O9S (527.1685904000001)
Cys Glu Asn Tyr
C21H29N5O9S (527.1685904000001)
Cys Glu Tyr Asn
C21H29N5O9S (527.1685904000001)
Cys Asn Glu Tyr
C21H29N5O9S (527.1685904000001)
Cys Asn Tyr Glu
C21H29N5O9S (527.1685904000001)
Cys Gln Asp Tyr
C21H29N5O9S (527.1685904000001)
Cys Gln Tyr Asp
C21H29N5O9S (527.1685904000001)
Cys Tyr Asp Gln
C21H29N5O9S (527.1685904000001)
Cys Tyr Glu Asn
C21H29N5O9S (527.1685904000001)
Cys Tyr Asn Glu
C21H29N5O9S (527.1685904000001)
Cys Tyr Gln Asp
C21H29N5O9S (527.1685904000001)
Asp Cys Gln Tyr
C21H29N5O9S (527.1685904000001)
Asp Cys Tyr Gln
C21H29N5O9S (527.1685904000001)
Asp Gln Cys Tyr
C21H29N5O9S (527.1685904000001)
Asp Gln Tyr Cys
C21H29N5O9S (527.1685904000001)
Asp Tyr Cys Gln
C21H29N5O9S (527.1685904000001)
Asp Tyr Gln Cys
C21H29N5O9S (527.1685904000001)
Glu Cys Asn Tyr
C21H29N5O9S (527.1685904000001)
Glu Cys Tyr Asn
C21H29N5O9S (527.1685904000001)
Glu Asn Cys Tyr
C21H29N5O9S (527.1685904000001)
Glu Asn Tyr Cys
C21H29N5O9S (527.1685904000001)
Glu Tyr Cys Asn
C21H29N5O9S (527.1685904000001)
Glu Tyr Asn Cys
C21H29N5O9S (527.1685904000001)
Asn Cys Glu Tyr
C21H29N5O9S (527.1685904000001)
Asn Cys Tyr Glu
C21H29N5O9S (527.1685904000001)
Asn Glu Cys Tyr
C21H29N5O9S (527.1685904000001)
Asn Glu Tyr Cys
C21H29N5O9S (527.1685904000001)
Asn Tyr Cys Glu
C21H29N5O9S (527.1685904000001)
Asn Tyr Glu Cys
C21H29N5O9S (527.1685904000001)
Gln Cys Asp Tyr
C21H29N5O9S (527.1685904000001)
Gln Cys Tyr Asp
C21H29N5O9S (527.1685904000001)
Gln Asp Cys Tyr
C21H29N5O9S (527.1685904000001)
Gln Asp Tyr Cys
C21H29N5O9S (527.1685904000001)
Gln Tyr Cys Asp
C21H29N5O9S (527.1685904000001)
Gln Tyr Asp Cys
C21H29N5O9S (527.1685904000001)
Tyr Cys Asp Gln
C21H29N5O9S (527.1685904000001)
Tyr Cys Glu Asn
C21H29N5O9S (527.1685904000001)
Tyr Cys Asn Glu
C21H29N5O9S (527.1685904000001)
Tyr Cys Gln Asp
C21H29N5O9S (527.1685904000001)
Tyr Asp Cys Gln
C21H29N5O9S (527.1685904000001)
Tyr Asp Gln Cys
C21H29N5O9S (527.1685904000001)
Tyr Glu Cys Asn
C21H29N5O9S (527.1685904000001)
Tyr Glu Asn Cys
C21H29N5O9S (527.1685904000001)
Tyr Asn Cys Glu
C21H29N5O9S (527.1685904000001)
Tyr Asn Glu Cys
C21H29N5O9S (527.1685904000001)
Tyr Gln Cys Asp
C21H29N5O9S (527.1685904000001)
Tyr Gln Asp Cys
C21H29N5O9S (527.1685904000001)
Pirozadil
C27H29NO10 (527.1791374000001)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent
5(6)-CARBOXYTETRAMETHYLRHODAMINE N-SUCCINIMIDYL ESTER
C29H25N3O7 (527.1692419999999)
5(6)-TAMRA, SE [5-(and-6)-Carboxytetramethylrhodamine, succinimidyl ester]
C29H25N3O7 (527.1692419999999)
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide
(7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(3-pyridinyl)-4-quinolinecarboxamide
(7R,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(2R,4S)-4-[[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]methyl]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-2-carboxylic acid
C27H29NO10 (527.1791374000001)
9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
Beperidium iodide
Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(2s,3s,4r,5r)-2-[(s)-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl](hydroxy)methyl]oxane-2,3,4,5-tetrol
C27H29NO10 (527.1791374000001)
(8s,10s)-8-acetyl-10-{[(2r,4r,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(8s,10r)-10-{[(2s,4r,5r,6r)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
18-ethyl-9,10,20-trihydroxy-8-methoxy-7,20,23-trimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15-trione
C27H29NO10 (527.1791374000001)
(8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(5s,7r,8s,9r,10r,18r,20r)-18-ethyl-9,10,20-trihydroxy-8-methoxy-7,20,23-trimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15-trione
C27H29NO10 (527.1791374000001)
2-({17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}(hydroxy)methyl)oxane-2,3,4,5-tetrol
C27H29NO10 (527.1791374000001)